Draganfly Receives Purchase Order for its Commander 3XL and Draganfly Flex FPV Drones for deployment within the U.S. Department of Defense
September 05, 2024 07:15 ET
|
Draganfly Inc
Commander 3XL to be used to carry and deploy swarms of Draganfly Flex FPV Drones. Saskatoon, Sask, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A)...
BioNTech präsentiert auf dem ESMO-Kongress 2024 klinische Daten-Updates aus dem mRNA und immunmodulatorischen Onkologie-Portfolio
September 05, 2024 07:15 ET
|
BioNTech SE
MAINZ, Deutschland, 05. September 2024 – BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) wird auf dem diesjährigen Kongress der European Society for Molecular Oncology („ESMO“), der vom...
BioNTech to Present Clinical Data Updates Across mRNA and Immunomodulatory Oncology Portfolio at ESMO Congress 2024
September 05, 2024 07:15 ET
|
BioNTech SE
MAINZ, Germany, September 05, 2024 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data for selected assets from its multi-platform oncology pipeline at the...
Optery Named Finalist for Attack Surface Management in Cyber Defense Magazine’s 12th Annual InfoSec Awards
September 05, 2024 07:15 ET
|
Optery
Optery, the leader in enterprise personal data removal, named finalist for Attack Surface Management in Cyber Defense Magazine’s InfoSec Awards.
Major shareholder announcement
September 05, 2024 07:07 ET
|
Novozymes A/S
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital...
Varonis Systems, Inc. Announces Proposed Offering of $350 Million of Convertible Senior Notes
September 05, 2024 07:06 ET
|
Varonis Systems, Inc.
NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Varonis Systems, Inc. (Nasdaq: VRNS) (“Company” or “Varonis”) announced today its intention to offer $350.0 million aggregate principal amount of...
Bioengineered Protein Drugs Strategic Research Report 2024: Market to Reach $329.9 Billion by 2030 - Personalized Medicine Trends Strengthen Business Case
September 05, 2024 07:05 ET
|
Research and Markets
Dublin, Sept. 05, 2024 (GLOBE NEWSWIRE) -- The "Bioengineered Protein Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Unicycive Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
September 05, 2024 07:03 ET
|
Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the...
SAIC Announces Second Quarter of Fiscal Year 2025 Results
September 05, 2024 07:01 ET
|
SAIC, Inc.
Revenues of $1.82 billion; 2% organic growth Net income of $81 million; Adjusted EBITDA(1) of $170 million or 9.4% of revenuesDiluted earnings per share of $1.58; Adjusted diluted earnings per...
Gilat Secures Over $12 Million Orders for SkyEdge Platforms from Leading Satellite Operator
September 05, 2024 07:01 ET
|
Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, announced...